Our Mission
Developed in 2023 by Professor Wayne F. Reed and Professor Curtis W. Jarand, Tulane’s cuvette-based spectroscopic technology brings a physicist’s perspective to the challenges of biologic drug stability and characterization. The technology reflects a broader vision to collaborate with biopharma partners to improve drug development efficiency. Our team believes in the continuous advancement of scientific methods to better serve researchers, industry, and ultimately, patients around the world.
Our Niche
Our efficient approach to formulation optimization delivers more data in less time by covering a wide range of conditions in a single sweep. This comprehensive data provides precise, actionable results, filling in key gaps and accelerating confident decision making across the development pipeline. The cuvette-based format integrates seamlessly with cuvette compatible instrumentation, allowing scientists to do more with their existing equipment.
Generate more data in less time with comprehensive, precise results.
-
Detect problematic instabilities early in development
-
Monitor the rate and reversibility of aggregation
-
Formulate complex or high-concentration biologics
-
Define design space to support manufacturing decisions
One continuous gradient delivers more data than dozens of discrete wells.
A New Layer of Insight, Without the Overhead
-
🧪 One sample, many conditions
Replace discrete sample prep with a continuous gradient -
🔍 More than endpoint data
Monitor behavior in real time as conditions evolve -
⚙️Standard cuvettes, no special consumables
Drop into existing workflows, no custom plates required -
🔧 Do more with what you already have
No need to replace, just amplify what your current tools can do
Connect with Us at PepTalk January 2026!
Showcasing our cuvette-based spectroscopy technology and exploring new collaboration opportunities.
Recognized with poster award at PEGS 2025
Based in New Orleans, Louisiana
Tulane University
Percival Stern Laboratory
